Australia markets closed
  • ALL ORDS

    7,325.80
    +8.30 (+0.11%)
     
  • ASX 200

    7,063.50
    +4.90 (+0.07%)
     
  • AUD/USD

    0.7737
    -0.0018 (-0.23%)
     
  • OIL

    63.07
    -0.39 (-0.61%)
     
  • GOLD

    1,777.30
    +10.50 (+0.59%)
     
  • BTC-AUD

    80,502.58
    -1,323.58 (-1.62%)
     
  • CMC Crypto 200

    1,398.97
    +7.26 (+0.52%)
     
  • AUD/EUR

    0.6452
    -0.0021 (-0.32%)
     
  • AUD/NZD

    1.0822
    +0.0016 (+0.15%)
     
  • NZX 50

    12,684.73
    +48.18 (+0.38%)
     
  • NASDAQ

    14,041.91
    +15.71 (+0.11%)
     
  • FTSE

    7,019.53
    +36.03 (+0.52%)
     
  • Dow Jones

    34,200.67
    +164.68 (+0.48%)
     
  • DAX

    15,459.75
    +204.42 (+1.34%)
     
  • Hang Seng

    28,969.71
    +176.57 (+0.61%)
     
  • NIKKEI 225

    29,683.37
    +40.68 (+0.14%)
     

Bristol Myers Squibb to Take Part in the Cowen Virtual 41st Annual Health Care Conference

·1-min read

Bristol Myers Squibb (NYSE: BMY) today announced that the company will participate in a fireside chat at the Cowen Virtual 41st Annual Health Care Conference, which will be webcast on Wednesday, March 3, 2021. Samit Hirawat, M.D., Executive Vice President, Chief Medical Officer, Global Drug Development will answer questions about the company at 10:20 a.m. ET.

Investors and the general public are invited to listen to a live webcast of the session at http://investor.bms.com. Material related to the company’s presentation will be available at the same website at the start of the live webcast. An archived edition of the session will be available later that day.

About Bristol Myers Squibb

Bristol Myers Squibb is a global biopharmaceutical company whose mission is to discover, develop and deliver innovative medicines that help patients prevail over serious diseases. For more information about Bristol Myers Squibb, visit us at BMS.com or follow us on LinkedIn, Twitter, YouTube, Facebook, and Instagram.

CorporateFinancial-News

View source version on businesswire.com: https://www.businesswire.com/news/home/20210224005060/en/

Contacts

Bristol Myers Squibb

Media:
media@bms.com

Investor Relations:
Tim Power, 609-252-7509, timothy.power@bms.com
Nina Goworek, 908-673-9711, nina.goworek@bms.com